Zhigui Li

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction: ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells.

Correction: ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells.

Journal: Cell communication and signaling : CCS

Published: September 02, 2024

The NR3C2-SIRT1 signaling axis promotes autophagy and inhibits epithelial mesenchymal transition in colorectal cancer.

The NR3C2-SIRT1 signaling axis promotes autophagy and inhibits epithelial mesenchymal transition in colorectal cancer.

Journal: Cell death & disease

Published: July 04, 2024

ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells.

ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells.

Journal: Cell communication and signaling : CCS

Published: May 15, 2024

c-MET is an important marker for acid-driven metastasis and anti-immune in colorectal cancer.

c-MET is an important marker for acid-driven metastasis and anti-immune in colorectal cancer.

Journal: International immunopharmacology

Published: April 24, 2024

High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.

High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.

Journal: Cancer medicine

Published: February 25, 2024

Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer.

Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: September 14, 2023

Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma.

Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma.

Journal: Translational cancer research

Published: May 26, 2023

Deciphering the Clinical Significance and Kinase Functions of GSK3α in Colon Cancer by Proteomics and Phosphoproteomics.

Deciphering the Clinical Significance and Kinase Functions of GSK3α in Colon Cancer by Proteomics and Phosphoproteomics.

Journal: Molecular & cellular proteomics : MCP

Published: December 17, 2022

Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database.

Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database.

Journal: Current oncology (Toronto, Ont.)

Published: December 04, 2022

NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK.

NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK.

Journal: Journal of cellular and molecular medicine

Published: July 12, 2022

TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer.

TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer.

Journal: Frontiers in oncology

Published: May 18, 2022

Age-Associated Proteomic Signatures and Potential Clinically Actionable Targets of Colorectal Cancer.

Age-Associated Proteomic Signatures and Potential Clinically Actionable Targets of Colorectal Cancer.

Journal: Molecular & cellular proteomics : MCP

Published: November 23, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026